Cite

HARVARD Citation

    El‐Adl, K. et al. (2021). Design, synthesis, docking, ADMET profile, and anticancer evaluations of novel thiazolidine‐2, 4‐dione derivatives as VEGFR‐2 inhibitors. Archiv der Pharmazie. 354 (7), p. n/a. [Online]. 
  
Back to record